2'-C-Methyladenosine
Based on 3 publication(s) in Google Scholar
2'-C-Methyladenosine is an inhibitor of hepatitis C virus (HCV) replication. 2'-C-Methyladenosine inhibits HCV replicon and NS5B-catalyzed RNA synthesis with IC50 values of 0.3μM and 1.9 μM, respectively. 2'-C-Methyladenosine also potently inhibits LRV1 in Leishmania guyanensis (Lgy) and Leishmania braziliensis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.50%
- CAS No.: 15397-12-3
- Formule: C11H15N5O4
- Masse moléculaire:281.27
-
Stockage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications Citing Use of MedChemExpress (MCE) 2'-C-Methyladenosine
More
Activité biologique
IC50: 0.3μM (HCV replicon); 1.9 μM (NS5B)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | CC50 |
>50 μM
Compound: 2
|
Cytotoxicity against human A549 cells assessed as intracellular ATP level by Celltiter-Glo luminescent assay
Cytotoxicity against human A549 cells assessed as intracellular ATP level by Celltiter-Glo luminescent assay
|
[PMID: 20457821] |
| A549 | EC50 |
1.12 μM
Compound: 2
|
Antiviral activity against at 0.3 MOI Dengue virus 2 infected in human A549 cells assessed as level of E protein after 48 hrs by ELISA
Antiviral activity against at 0.3 MOI Dengue virus 2 infected in human A549 cells assessed as level of E protein after 48 hrs by ELISA
|
[PMID: 20457821] |
| Caco-2 | GI50 |
>100 μM
Compound: 2'-Me-Ado
|
Antitumor activity against human CaCo2 cells after 48 hrs by MTS assay
Antitumor activity against human CaCo2 cells after 48 hrs by MTS assay
|
[PMID: 18588281] |
| HT-29 | GI50 |
>100 μM
Compound: 2'-Me-Ado
|
Antitumor activity against human HT29 cells after 48 hrs by MTS assay
Antitumor activity against human HT29 cells after 48 hrs by MTS assay
|
[PMID: 18588281] |
| HT-29 | IC50 |
>100 μM
Compound: 2 (2'-Me-Ado)
|
In vitro inhibitory activity against human colon carcinoma HT-29 cell line
In vitro inhibitory activity against human colon carcinoma HT-29 cell line
|
[PMID: 16033277] |
| Huh-5-2 | CC50 |
>33 μM
Compound: 2'-C-Methyladenosine
|
Cytotoxicity against human Huh5-2 cells after 3 days by MTT assay
Cytotoxicity against human Huh5-2 cells after 3 days by MTT assay
|
[PMID: 18625766] |
| Huh-5-2 | CC50 |
>50 μM
Compound: 1
|
Cytotoxicity against human Huh5-2 cells
Cytotoxicity against human Huh5-2 cells
|
[PMID: 19523820] |
| Huh-5-2 | EC50 |
0.12 μM
Compound: 2'-C-Methyladenosine
|
Antiviral activity against Hepatitis C virus genotype 1b infected in human Huh5-2 cells assessed as reduction in replicon RNA after 4 days by luciferase assay
Antiviral activity against Hepatitis C virus genotype 1b infected in human Huh5-2 cells assessed as reduction in replicon RNA after 4 days by luciferase assay
|
[PMID: 18625766] |
| Huh-5-2 | EC50 |
0.25 μM
Compound: 1
|
Antiviral activity against HCV assessed as inhibition of viral replicon replication in human Huh5-2 cells
Antiviral activity against HCV assessed as inhibition of viral replicon replication in human Huh5-2 cells
|
[PMID: 19523820] |
| Huh-7 | CC50 |
>100 μM
Compound: 1
|
Cytotoxicity against Huh7 cells after 24 hrs by MTS assay
Cytotoxicity against Huh7 cells after 24 hrs by MTS assay
|
[PMID: 17521911] |
| Huh-7 | CC50 |
>100 μM
Compound: 2'CMeA
|
Cytotoxicity against human Huh7 cells harboring con1 replicon after 3 days by MTT assay
Cytotoxicity against human Huh7 cells harboring con1 replicon after 3 days by MTT assay
|
[PMID: 17997319] |
| Huh-7 | CC50 |
>100 μM
Compound: 2'CmeA
|
Cytotoxicity against human Huh7 cells after 3 days by MTT method
Cytotoxicity against human Huh7 cells after 3 days by MTT method
|
[PMID: 18078757] |
| Huh-7 | CC50 |
15 μM
Compound: 2
|
Cytotoxicity against Huh7 cells by MTS assay
Cytotoxicity against Huh7 cells by MTS assay
|
[PMID: 16368235] |
| Huh-7 | CC50 |
55 μM
Compound: 2 mA
|
Cytotoxicity against human HuH7 cells infected with HCV1b after 3 days by MTS assay
Cytotoxicity against human HuH7 cells infected with HCV1b after 3 days by MTS assay
|
[PMID: 22100256] |
| Huh-7 | CC50 |
66 μM
Compound: 2'-C-Me A
|
Cytotoxicity against human HuH7 cells after 24 hrs by MTS assay
Cytotoxicity against human HuH7 cells after 24 hrs by MTS assay
|
[PMID: 22578461] |
| Huh-7 | EC50 |
>100 μM
Compound: 2
|
Antiviral activity against HCV genotype1 infected in human Huh7 cells assessed as reduction of viral replication by steady-Glo luciferase assay
Antiviral activity against HCV genotype1 infected in human Huh7 cells assessed as reduction of viral replication by steady-Glo luciferase assay
|
[PMID: 20627592] |
| Huh-7 | EC50 |
0.2 μM
Compound: 1
|
Antiviral activity against HCV genotype 1b in Huh7 cells assessed as inhibition of viral RNA replication after 72 hrs by ribonuclease protection assay
Antiviral activity against HCV genotype 1b in Huh7 cells assessed as inhibition of viral RNA replication after 72 hrs by ribonuclease protection assay
|
[PMID: 17521911] |
| Huh-7 | EC50 |
0.2 μM
Compound: 2 mA
|
Antiviral activity against HCV genotype 1b infected in human HuH7 cells after 3 days by renilla luciferase reporter assay
Antiviral activity against HCV genotype 1b infected in human HuH7 cells after 3 days by renilla luciferase reporter assay
|
[PMID: 22100256] |
| Huh-7 | EC50 |
0.23 μM
Compound: 2'CMeA
|
Antiviral activity against HCV 1b Con1 replicon in Huh7 cells
Antiviral activity against HCV 1b Con1 replicon in Huh7 cells
|
[PMID: 17997319] |
| Huh-7 | EC50 |
0.25 μM
Compound: 1
|
Antiviral activity against HCV genotype 1b in Huh7 cells assessed as inhibition of viral RNA replication after 24 hrs by ribonuclease protection assay
Antiviral activity against HCV genotype 1b in Huh7 cells assessed as inhibition of viral RNA replication after 24 hrs by ribonuclease protection assay
|
[PMID: 17521911] |
| Huh-7 | EC50 |
0.35 μM
Compound: 2'-C-Me A
|
Antiviral activity against HCV genotype 1b infected in human HuH7 cells assessed as cytoprotection after 24 hrs
Antiviral activity against HCV genotype 1b infected in human HuH7 cells assessed as cytoprotection after 24 hrs
|
[PMID: 22578461] |
| K562 | GI50 |
16 μM
Compound: 2'-Me-Ado
|
Antitumor activity against human K562 cells after 48 hrs by MTS assay
Antitumor activity against human K562 cells after 48 hrs by MTS assay
|
[PMID: 18588281] |
| K562 | IC50 |
>100 μM
Compound: 2 (2'-Me-Ado)
|
In vitro inhibitory activity against human leukemia K562IU cell line
In vitro inhibitory activity against human leukemia K562IU cell line
|
[PMID: 16033277] |
| K562 | IC50 |
16 μM
Compound: 2 (2'-Me-Ado)
|
In vitro inhibitory activity against human myelogenous leukemia K562 cell line
In vitro inhibitory activity against human myelogenous leukemia K562 cell line
|
[PMID: 16033277] |
| MCF7 | GI50 |
>100 μM
Compound: 2'-Me-Ado
|
Antitumor activity against human MCF7 cells after 48 hrs by MTS assay
Antitumor activity against human MCF7 cells after 48 hrs by MTS assay
|
[PMID: 18588281] |
| MCF7 | IC50 |
>100 μM
Compound: 2 (2'-Me-Ado)
|
In vitro inhibitory activity against human breast carcinoma MCF-7 cell line
In vitro inhibitory activity against human breast carcinoma MCF-7 cell line
|
[PMID: 16033277] |
| MDBK441 | CC50 |
>14 μg/mL
Compound: 2-C-methyl adenosine
|
Cytotoxicity against MDBK cells
Cytotoxicity against MDBK cells
|
[PMID: 16610805] |
? 2'-C-Methyladenosine inhibits NS5B-catalyzed RNA synthesis with an IC50 values of 1.9 μM[1].
? 2′-C-methyladenosine potently inhibits LRV1 in Leishmania guyanensis (Lgy) and Leishmania braziliensis[2]
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 15397-12-3
-
Appearance Solid
-
Masse moléculaire 281.27
-
Formule C11H15N5O4
-
Color White to off-white
-
SMILES
OC[C@@H]1[C@@H](O)[C@@](C)(O)[C@H](N2C3=NC=NC(N)=C3N=C2)O1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
-
iScience
Mitochondrial dysfunction activates ADAMTS-5 expression via mt-dsRNA-PKR-Spi-1 axis in osteoarthritic chondrocytes. [Abstract]2026 May 20;29(6):115980. PMID: 42211122 -
Solvant et solubilité
DMSO : 31.25 mg/mL (111.10 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (278 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Steven S Carroll, et al. Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs. J Biol Chem. 2003 Apr 4;278(14):11979-84. [Content Brief]
[2]. John I Robinson, et al. Concentration of 2'C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase. J Biol Chem. 2018 Apr 27;293(17):6460-6469. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.5553 mL | 17.7765 mL | 35.5530 mL | 88.8826 mL |
| 5 mM | 0.7111 mL | 3.5553 mL | 7.1106 mL | 17.7765 mL | |
| 10 mM | 0.3555 mL | 1.7777 mL | 3.5553 mL | 8.8883 mL | |
| 15 mM | 0.2370 mL | 1.1851 mL | 2.3702 mL | 5.9255 mL | |
| 20 mM | 0.1778 mL | 0.8888 mL | 1.7777 mL | 4.4441 mL | |
| 25 mM | 0.1422 mL | 0.7111 mL | 1.4221 mL | 3.5553 mL | |
| 30 mM | 0.1185 mL | 0.5926 mL | 1.1851 mL | 2.9628 mL | |
| 40 mM | 0.0889 mL | 0.4444 mL | 0.8888 mL | 2.2221 mL | |
| 50 mM | 0.0711 mL | 0.3555 mL | 0.7111 mL | 1.7777 mL | |
| 60 mM | 0.0593 mL | 0.2963 mL | 0.5926 mL | 1.4814 mL | |
| 80 mM | 0.0444 mL | 0.2222 mL | 0.4444 mL | 1.1110 mL | |
| 100 mM | 0.0356 mL | 0.1778 mL | 0.3555 mL | 0.8888 mL |